GlassScriptPhysician profile
Ashley Walpole
NPI 1164804936
$4,348.02
in general payments reported to CMS, 2019-2025
20 companies · $1,375 in 2025
The $1,375 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $392 · 2023: $838 · 2024: $1,297 · 2025: $1,375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,338 · Grant: $90.00 · Education: $82.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,337.92 |
| Grant | $90.00 |
| Education | $82.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,302.22 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,089.77 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Insmed, INC. | $428.32 | 2023-2025 | Arikayce, Brinsupri |
| Calliditas Therapeutics US INC. | $234.58 | 2024 | |
| Zoll Respicardia, INC. | $173.41 | 2024 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.24 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $161.33 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $160.01 | 2024-2025 | Inspire |
| Itamar Medical INC | $120.74 | 2024-2025 | Watchpatone |
| Inogen, INC. | $118.17 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $74.69 | 2025 | Ohtuvayre |
| Neurocrine Biosciences, INC. | $64.84 | 2022-2023 | Ingrezza, Ongentys |
| Baxter Healthcare | $58.81 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Viatris Specialty LLC | $41.86 | 2025 | Yupelri |
| Mylan Specialty L.P. | $38.74 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $33.45 | 2021-2023 | |
| Boston Scientific Corporation | $31.80 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Genentech USA, INC. | $16.30 | 2022 | |
| Amgen INC. | $15.18 | 2023 | Tezspire |
| Avanir Pharmaceuticals, INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Walpole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.